Mishri Solvochem Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1173.18%
- Profit Growth 97.07%
- Ebitda 96.24%
- Net Worth -0.12%
- Total Assets 32.91%
About Mishri Solvochem
Mishri Solvochem Private Limited (MSPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 August 2007 and has a history of 17 years and five months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Neel Shah and Ramachandra Misra serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MH2007PTC173554
-
Company No.
173554
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Aug 2007
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Mishri Solvochem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neel Shah
|
Additional Director | 07-Aug-2012 | Current |
|
Ramachandra Misra
|
Director | 28-Aug-2007 | Current |
Financial Performance of Mishri Solvochem.
Mishri Solvochem Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 1173.18% increase. The company also saw a substantial improvement in profitability, with a 97.07% increase in profit. The company's net worth dipped by a decrease of 0.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mishri Solvochem?
In 2018, Mishri Solvochem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sang-Deep Acid-Chem Private LimitedNeel Shah is a mutual person
-
Nimp Healthcare Private LimitedNeel Shah is a mutual person
-
Jhs Chemi Pharma Private LimitedNeel Shah and Ramachandra Misra are mutual person
-
Sangdeep Pharmachem Private Limited
Neel Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mishri Solvochem?
Unlock and access historical data on people associated with Mishri Solvochem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mishri Solvochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mishri Solvochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
